Amylyx Pharmaceuticals discussed Q1 2025 earnings on Thursday

Amylyx Pharmaceuticals reported its first-quarter 2025 earnings, with details discussed during a conference call on Thursday. The call included updates from company executives on financial results and future plans. The earnings call featured presentations from key Amylyx executives, including the Co-CEOs, Chief Medical Officer, and Chief Financial Officer. Discussions covered financial performance and forward-looking statements regarding the company's outlook. Participants in the call included analysts from various financial institutions, who had the opportunity to ask questions. The call was recorded and is available for review.